BACKGROUND: Tissue imprinting can generate molecular marker maps of tumor cells at deep surgical margins. The purpose of this study was to evaluate the feasibility of this method for detection of residual head and neck squamous cell carcinoma (HNSCC). METHODS: Paired fresh tissue and nitrocellulose membrane imprints of tumor and deep margins were collected from 17 HNSCC resections. DNA was amplified using quantitative methylation-specific polymerase chain reaction (qMSP) for p16, DCC, KIF1A, and EDNRB. Levels of methylation in tumors and deep margins were compared. RESULTS: DNA from imprints was adequate for qMSP. Hypermethylation of target genes was present in 12 of 17 tumors and in 8 deep margins. Methylation level was better from margin imprints than tissue. During follow-up (median, 13 months), local or regional recurrences occurred in 6 cases of which 5 had molecularly positive margins. CONCLUSION: Tissue imprinting is feasible for molecular detection of residual tumor at deep surgical margins and may correlate with locoregional recurrence.
BACKGROUND: Tissue imprinting can generate molecular marker maps of tumor cells at deep surgical margins. The purpose of this study was to evaluate the feasibility of this method for detection of residual head and neck squamous cell carcinoma (HNSCC). METHODS: Paired fresh tissue and nitrocellulose membrane imprints of tumor and deep margins were collected from 17 HNSCC resections. DNA was amplified using quantitative methylation-specific polymerase chain reaction (qMSP) for p16, DCC, KIF1A, and EDNRB. Levels of methylation in tumors and deep margins were compared. RESULTS: DNA from imprints was adequate for qMSP. Hypermethylation of target genes was present in 12 of 17 tumors and in 8 deep margins. Methylation level was better from margin imprints than tissue. During follow-up (median, 13 months), local or regional recurrences occurred in 6 cases of which 5 had molecularly positive margins. CONCLUSION: Tissue imprinting is feasible for molecular detection of residual tumor at deep surgical margins and may correlate with locoregional recurrence.
Authors: I Sardi; A Franchi; G Ferriero; A Frittelli; L Bruschini; E Montali; O Gallo Journal: Genes Chromosomes Cancer Date: 2000-11 Impact factor: 5.006
Authors: M P Tabor; R H Brakenhoff; V M van Houten; J A Kummer; M H Snel; P J Snijders; G B Snow; C R Leemans; B J Braakhuis Journal: Clin Cancer Res Date: 2001-06 Impact factor: 12.531
Authors: Viola M M van Houten; Maarten P Tabor; Michiel W M van den Brekel; J Alain Kummer; Fedor Denkers; Janny Dijkstra; René Leemans; Isaäc van der Waal; Gordon B Snow; Ruud H Brakenhoff Journal: J Pathol Date: 2002-12 Impact factor: 7.996
Authors: M Partridge; S R Li; S Pateromichelakis; R Francis; E Phillips; X H Huang; F Tesfa-Selase; J D Langdon Journal: Clin Cancer Res Date: 2000-07 Impact factor: 12.531
Authors: Boudewijn J M Braakhuis; Maarten P Tabor; C René Leemans; Isaac van der Waal; Gordon B Snow; Ruud H Brakenhoff Journal: Head Neck Date: 2002-02 Impact factor: 3.147
Authors: David Goldenberg; Susan Harden; Brett G Masayesva; Patrick Ha; Nicole Benoit; William H Westra; Wayne M Koch; David Sidransky; Joseph A Califano Journal: Arch Otolaryngol Head Neck Surg Date: 2004-01
Authors: Viola M M van Houten; C René Leemans; J Alain Kummer; Janny Dijkstra; Dirk J Kuik; Michiel W M van den Brekel; Gordon B Snow; Ruud H Brakenhoff Journal: Clin Cancer Res Date: 2004-06-01 Impact factor: 12.531
Authors: J A Brennan; L Mao; R H Hruban; J O Boyle; Y J Eby; W M Koch; S N Goodman; D Sidransky Journal: N Engl J Med Date: 1995-02-16 Impact factor: 91.245
Authors: Michael M Li; Sidharth V Puram; Dustin A Silverman; Matthew O Old; James W Rocco; Stephen Y Kang Journal: Ann Surg Oncol Date: 2019-08-05 Impact factor: 5.344